Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'-Methodological challenges in combining miRNAs as circulating biomarkers.
作者信息
Verderio P, Bottelli S, Lecchi M, Plebani M, Gariboldi M, Pizzamiglio S, Ciniselli C M
机构信息
Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, via G. Venezian 1, 20133 Milano, Italy.
Molecular Genetics of Cancer, Fondazione Istituto FIRC di Oncologia Molecolare, via Adamello 16, 20139 Milano, Italy.
出版信息
Br J Cancer. 2016 May 10;114(10):e5. doi: 10.1038/bjc.2016.1. Epub 2016 Apr 21.
Abstract
摘要
相似文献
1
Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'-Methodological challenges in combining miRNAs as circulating biomarkers.关于“循环游离微小RNA作为三阴性乳腺癌生物标志物”的评论——将微小RNA作为循环生物标志物进行组合时的方法学挑战。
Br J Cancer. 2016 May 10;114(10):e5. doi: 10.1038/bjc.2016.1. Epub 2016 Apr 21.
2
Response to: Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'.对《关于循环游离微小RNA作为三阴性乳腺癌生物标志物的评论》的回应
Br J Cancer. 2016 May 10;114(10):e6. doi: 10.1038/bjc.2016.2. Epub 2016 Apr 21.
3
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.miR-105/93-3p 促进化疗耐药，循环 miR-105/93-3p 可作为三阴性乳腺癌的诊断生物标志物。
Breast Cancer Res. 2017 Dec 19;19(1):133. doi: 10.1186/s13058-017-0918-2.
4
miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers.miR-10b、miR-26a、miR-146a和miR-153在三阴性与非三阴性乳腺癌中的表达：潜在生物标志物
Pathol Oncol Res. 2017 Oct;23(4):815-827. doi: 10.1007/s12253-017-0188-4. Epub 2017 Jan 18.
5
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.鉴定miR-10b、miR-26a、miR-146a和miR-153作为潜在的三阴性乳腺癌生物标志物。
Cell Oncol (Dordr). 2015 Dec;38(6):433-42. doi: 10.1007/s13402-015-0239-3. Epub 2015 Sep 21.
6
Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.在沙特女性乳腺癌患者的血浆中检测到肿瘤抑制 miRNA let-7 和 miR-195 的稳健表达。
BMC Cancer. 2017 Nov 28;17(1):799. doi: 10.1186/s12885-017-3776-5.
7
MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.微小RNA-148a具有抑制转移的功能，并可作为三阴性乳腺癌的预后指标。
Oncotarget. 2016 Apr 12;7(15):20381-94. doi: 10.18632/oncotarget.7953.
8
MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.三阴性乳腺癌中MicroRNA失调揭示了miR-498在调节BRCA1表达中的作用。
Oncotarget. 2016 Apr 12;7(15):20068-79. doi: 10.18632/oncotarget.7705.
9
miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.miR-629-3p可能作为三阴性乳腺癌肺转移的一种新型生物标志物和潜在治疗靶点。
Breast Cancer Res. 2017 Jun 19;19(1):72. doi: 10.1186/s13058-017-0865-y.
10
Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.印度三阴性乳腺癌女性配对血清和组织样本中特定miRNA特征的鉴定
PLoS One. 2016 Jul 12;11(7):e0158946. doi: 10.1371/journal.pone.0158946. eCollection 2016.
引用本文的文献
1
A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosis.细胞外基质和干扰素相关特征的组合可鉴定出具有不良预后的高级别乳腺癌。
Mol Oncol. 2021 May;15(5):1345-1357. doi: 10.1002/1878-0261.12912. Epub 2021 Feb 19.
2
Developing miRNA signatures: a multivariate prospective.开发微小RNA特征：多变量前瞻性研究。
Br J Cancer. 2016 Jun 28;115(1):1-4. doi: 10.1038/bjc.2016.164.
本文引用的文献
1
Combining large number of weak biomarkers based on AUC.基于曲线下面积（AUC）合并大量弱生物标志物。
Stat Med. 2015 Dec 20;34(29):3811-30. doi: 10.1002/sim.6600. Epub 2015 Jul 30.
2
Circulating cell-free miRNAs as biomarker for triple-negative breast cancer.循环游离微小RNA作为三阴性乳腺癌的生物标志物
Br J Cancer. 2015 May 26;112(11):1751-9. doi: 10.1038/bjc.2015.143. Epub 2015 Apr 23.
3
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.透明报告个体预后或诊断的多变量预测模型（TRIPOD）：TRIPOD 声明。
Ann Intern Med. 2015 Jan 6;162(1):55-63. doi: 10.7326/M14-0697.
4
NqA: an R-based algorithm for the normalization and analysis of microRNA quantitative real-time polymerase chain reaction data.NqA：一种基于R的用于微小RNA定量实时聚合酶链反应数据标准化和分析的算法。
Anal Biochem. 2014 Sep 15;461:7-9. doi: 10.1016/j.ab.2014.05.020. Epub 2014 Jun 2.
5
Linear combination methods to improve diagnostic/prognostic accuracy on future observations.用于提高对未来观察结果的诊断/预后准确性的线性组合方法。
Stat Methods Med Res. 2016 Aug;25(4):1359-80. doi: 10.1177/0962280213481053. Epub 2013 Apr 16.
6
Assessing the clinical relevance of oncogenic pathways in neoadjuvant breast cancer.评估致癌途径在新辅助乳腺癌中的临床相关性。
J Clin Oncol. 2012 Jun 1;30(16):1912-5. doi: 10.1200/JCO.2012.41.7386. Epub 2012 Apr 16.
7
Biomarkers for Early Cancer Detection - Methodological Aspects.早期癌症检测的生物标志物——方法学方面
Breast Care (Basel). 2010;5(2):62-65. doi: 10.1159/000303956. Epub 2010 Apr 21.
8
MicroRNA signatures in human cancers.人类癌症中的微小RNA特征
Nat Rev Cancer. 2006 Nov;6(11):857-66. doi: 10.1038/nrc1997.
9
Combining diagnostic test results to increase accuracy.结合诊断测试结果以提高准确性。
Biostatistics. 2000 Jun;1(2):123-40. doi: 10.1093/biostatistics/1.2.123.
10
Simplifying a prognostic model: a simulation study based on clinical data.简化预后模型：基于临床数据的模拟研究
Stat Med. 2002 Dec 30;21(24):3803-22. doi: 10.1002/sim.1422.
Zotero 插件